RainDance Launches Targeted FFPE Sequencing Products; Partners with NuGen on Sample Prep | GenomeWeb

This story was originally published Feb. 2.

RainDance Technologies has launched a product for targeted sequencing of DNA from formalin-fixed paraffin-embedded and fresh frozen tissues samples and has partnered with NuGen Technologies to develop an FFPE sample prep kit, the company said last week.

The new product, called the DeepSeq FFPE Solution, runs on the company's RDT 1000 microdroplet PCR instrument and lets researchers analyze up to 500 genomic targets at up to 50,000-fold coverage per loci, allowing them to discover rare mutations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.